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Abstract
Background: Propensity scores are widely used to deal with confounding bias in medical research. An incorrectly
specified propensity score model may lead to residual confounding bias; therefore it is essential to use diagnostics
to assess propensity scores in a propensity score analysis. The current use of propensity score diagnostics in the
medical literature is unknown. The objectives of this study are to (1) assess the use of propensity score diagnostics
in medical studies published in high-ranking journals, and (2) assess whether the use of propensity score
diagnostics differs between studies (a) in different research areas and (b) using different propensity score methods.
Methods: A PubMed search identified studies published in high-impact journals between Jan 1st 2014 and Dec
31st 2016 using propensity scores to answer an applied medical question. From each study we extracted
information regarding how propensity scores were assessed and which propensity score method was used.
Research area was defined using the journal categories from the Journal Citations Report.
Results: A total of 894 papers were included in the review. Of these, 187 (20.9%) failed to report whether the
propensity score had been assessed. Commonly reported diagnostics were p-values from hypothesis tests (36.6%)
and the standardised mean difference (34.6%). Statistical tests provided marginally stronger evidence for a
difference in diagnostic use between studies in different research areas (p = 0.033) than studies using different
propensity score methods (p = 0.061).
Conclusions: The use of diagnostics in the propensity score medical literature is far from optimal, with different
diagnostics preferred in different areas of medicine. The propensity score literature may improve with focused
efforts to change practice in areas where suboptimal practice is most common.
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Background
Whilst randomised controlled trials (RCTs) are the gold
standard for evaluating treatment effects, they are often
infeasible due to time, cost or ethical constraints. In
such situations, observational data may provide valuable
information. Unfortunately, observational data analyses
are subject to confounding bias. This occurs when pa-
tient characteristics that influence the outcome have un-
balanced distributions across treatment groups. Any
differences observed in the outcome between treatment
groups may be partly due to the differences in patient
characteristics.
Traditionally, multivariable regression is used to ac-
count for the differences in patient characteristics be-
tween treatment groups. However, this approach is not
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always suitable. For example, when the study outcome is
binary, a rule of thumb suggests that 10 events should
be observed per covariate included in the regression
model [1]. This could be infeasible if the outcome is rare
and there are many covariates to adjust for. Propensity
scores provide a potential solution to this problem.
Rosenbaum and Rubin [2] first introduced the propen-
sity score, defined as the probability of treatment assign-
ment conditional on baseline characteristics.
Additionally, they demonstrated that conditioning on
the propensity score will balance the distribution of
characteristics between treatment groups, reducing the
chance of confounding bias. Propensity scores are useful
for situations with rare binary outcomes because adjust-
ing for the propensity score only is sufficient to improve
balance on the measured covariates. They are also useful
in situations where the relationship between covariates
and treatment is better understood than the relationship
between covariates and outcome, since treatment is
modelled rather than outcome. Additionally, comparing
propensity score distributions between treatment groups
can help identify areas of non-overlap in covariate distri-
butions, which are often overlooked when using trad-
itional regression methods [3]. However, it is important
to note that propensity scores cannot account for un-
measured confounding: balance will only be improved
on covariates used to estimate the propensity score.
Most commonly, propensity scores are estimated using
logistic regression. Treatment assignment is regressed
on baseline characteristics and the predicted probabil-
ities are the estimated propensity scores. Assuming no
unmeasured confounding and no misspecification of the
propensity score model, unbiased estimates of treatment
effects can be obtained using one of four techniques:
matching, stratification, weighting or covariate adjust-
ment. We briefly describe these techniques here, but
readers are referred elsewhere for more details [2, 4–9].
Matching involves forming matched sets of treated and
control patients, on the basis of having similar propen-
sity scores. Stratification involves dividing patients into
equally sized strata based on their propensity score and
weighting involves assigning propensity-based weights to
each patient. Estimated treatment effects can then be ob-
tained by comparing outcomes in the matched set,
within strata (an overall estimate can be obtained by
pooling the strata-specific estimates) or in the weighted
sample. Finally, covariate adjustment is implemented by
including the propensity score as a covariate when
regressing outcome on treatment. Each of these tech-
niques aim to balance patient characteristics between
treatment groups, but misspecification of the propensity
score model could prevent achieving adequate balance,
thereby leading to residual confounding bias. Hence, an
essential step of propensity score implementation is
using appropriate diagnostics to assess the propensity
score and ensure that it has adequately reduced con-
founding bias. Many authors [10–17] have made recom-
mendations regarding appropriate use of diagnostics.
More specifically, they recommended against the use of
hypothesis tests comparing covariate means or propor-
tions and advocated using standardised differences.
Despite their introduction in 1983, propensity scores
were not commonly applied in the medical literature
until around 20 years later. More recently, they have be-
come increasingly popular [10]. In the last decade
(2007–2017) the number of articles returned from
searching ‘propensity scores’ in PubMed more than tri-
pled over each 5 year period. Following the increase in
use of propensity scores, a number of reviews [10, 11,
18–25] assessing their implementation were published.
Regrettably, each review found that propensity score im-
plementation was suboptimal, particularly regarding the
use of diagnostics. Many authors were not reporting the
use of any propensity score diagnostic, and those who
did were often using hypothesis tests, which are widely
discouraged. If appropriate diagnostics are not used to
demonstrate the balance of potential confounders
achieved by the propensity score, readers of the research
have no basis for trusting the results. Of the existing re-
views on the propensity score literature, only three [11,
19, 21] consider articles from all areas of medicine, and
these collectively include articles published up to 2012.
Since 2012, there has been numerous publications pro-
viding guidance on the use of propensity score diagnos-
tics [10–12, 14–17], or proposing new propensity score
diagnostics [26–29]. Considering these recent develop-
ments in methodology and guidance on practice, the use
of propensity score diagnostics in recent medical studies
may have improved. Therefore the aim of this review is
to update the literature on diagnostic use, but with a
focus on high-ranking journals. Such journals could be
considered more influential as they are often looked to-
wards as a beacon of best practice. Furthermore, it may
beneficial to know which types of studies are more or
less likely to report use of suboptimal diagnostics. This
information could help us to identify pockets of good
practice and areas where efforts to change practice
should be focused. Bearing this in mind, the objectives
of this review are to: (1) assess the use of propensity
score diagnostics in medical studies published in high-
ranking journals and (2) compare use of diagnostics be-
tween studies (a) in different research areas and (b)
using different propensity score methods.
Methods
Search strategy
A PubMed search was conducted on 13th November
2017 to identify articles using propensity scores. We
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searched for articles with “propensity score” or “propen-
sity matched” in the title, abstract or as a Medical Sub-
ject Heading (MeSH). The search was limited to
publications between 2014 and 2016 and to journals
which [1] were ranked in the top 10 by the 2013 Journal
Citation Report (JCR) impact factor in any JCR medicine
category and [2] had a JCR impact factor of at least 4
(the full text search string is given in Additional file 1).
Study selection
Studies which used propensity scores to answer an ap-
plied medical question were included. This includes
studies which aim to assess the effect of a health inter-
vention (e.g. drugs or surgical intervention), or the effect
of an exposure (e.g. alcohol), on a health related out-
come. Studies were excluded if they were methodo-
logical, editorials, reviews or letters. Titles and abstracts
were screened to assess eligibility.
Data extraction
Eligible studies were checked manually by one author
(EG) to extract information regarding which diagnostic
was used to assess the propensity score and which
method was used to condition on the propensity score.
For eligible journals, the research area and impact factor
was obtained from the JCR website (https://webofknow-
ledge.com).
To assess the reliability of the manual search for data
extraction, an automatic full-text search was conducted
by a second author (TW) using FileLocator Pro to iden-
tify which of the included articles used the ‘standardised
difference’, ‘c-statistic’ or the ‘Hosmer-Lemeshow test’ as
a propensity score diagnostic. These diagnostics were se-
lected because the variety of terms which could be used
to refer to these diagnostics is limited compared to other
diagnostics (e.g. a t-test may be referred to as hypothesis
test, significance test, testing equality of means etc.). For
any discrepancies between the two data extraction
methods, the article in question was manually checked
(EG). Most discrepancies (135/147; 92%) were due to the
full-text search either incorrectly selecting articles which
used the diagnostic for something other than propensity
scores, or incorrectly omitting articles where the authors
had referred to the diagnostic using different
terminology.
Data analysis
Multinomial logistic regression was used to investigate
whether or not there were differences in diagnostic use
between (a) studies in different research areas and (b)
studies using different propensity score methods. In both
models, the outcome was a categorical variable indicat-
ing which diagnostic was used: (1) hypothesis tests (2)
standardised differences (3) c-statistic, (4) the Hosmer-
Lemeshow test (5) eye-balling the data (i.e. informally
assessing balance by scanning the values in a table or fig-
ure comparing covariate means between treatment
groups), (6) other and (7) failed to report diagnostic use.
The ‘other’ category comprised of diagnostics that were
rarely observed (< 4% studies). The independent vari-
ables were indicators for either research area or propen-
sity score method and the categories used are the same
as those presented in Figs. 2, 3 and 4. Studies which used
multiple diagnostics were included in the model once
for each diagnostic used and this was accounted for by
using a robust standard error estimator which accounts
for non-independent observations [30].
The p-values associated with each model’s F-statistic
were reported as an informal measure of the strength of
evidence for differences in diagnostic use between
Fig. 1 Flowchart of study selection
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research areas and studies using different propensity
score methods. To further investigate possible differ-
ences in diagnostic use, we reported the proportion (and
associated 95% confidence interval) of studies using each
diagnostic by research area and propensity score
method. The 95% confidence intervals for proportions





where f −1ðyÞ ¼ ey1þey , p̂ and ŝ are estimates of the pro-
portion and associated standard error respsecitvely, and
t1−α=2;ϑ
is the ð1þ α=2Þth quantile of Student’s t distri-
bution with ϑ degrees of freedom. The logit transform-
ation of the confidence interval was used to ensure that
the limits lay between 0 and 1.
Results
The PubMed search identified 917 studies, of which 23
did not meet the inclusion criteria (Fig. 1). The
remaining 894 studies were included in the review (a list
of the included studies is given in Additional file 2).
Of the 894 studies included in the review, 187 (20.9%)
failed to report whether propensity score diagnostics
were used. A further 21 (2.3%) reported that the propen-
sity score had been assessed, but did not report how.
Where diagnostics were reported, the most common
were: p-values from hypothesis tests (36.6%), standar-
dised difference (34.6%), c-statistic (15.4%) and the
Hosmer-Lemeshow test (5.7%). Eye-balling the data after
adjustment to assess balance was reported in (4.3%)
studies. These percentages total to more than 100 since
many authors used multiple diagnostics.
The average impact factor (median [interquartile
range]) was highest among articles where balance was
assessed by eye-balling the data (9.3 [6.0, 14.9]). Order-
ing the remaining diagnostic categories by median im-
pact factor gives: propensity score assessed, but
diagnostic not reported (7.2 [6.0, 12.5]), standardised dif-
ference (7.0 [5.6, 12.5]), c-statistic (7.0 [5.5, 11.9]),
Hosmer-Lemeshow test (7.0 [5.4, 10.4]) p-values (7.0
[5.2, 9.8]), did not report diagnostic use (7.0 [5.3, 12.0])
Fig. 2 The proportion (95% Confidence Interval) of studies which did not report use of a propensity score diagnostic, by research area.
‘Assessment not reported’ refers to papers which did not specify whether propensity scores were assessed; ‘Diagnostic not reported’ refers to
papers which reported that assessment took place, but not how
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and other (6.1 [5.3,10.7]). The similarity in these median
indicates no discernible association between diagnostic
and impact factor.
Comparison of diagnostics between different research
areas
The most common research areas (defined as areas
containing 5% or more of the total number of stud-
ies) are listed in Figs. 2 and 3. There were 25 add-
itional research areas; these have been grouped
together into an ‘other’ category. The number of
studies in each of the additional research areas was
between 1 (0.11%) and 36 (4.03%). More details on
the additional research areas and how many studies
were in area is given in Additional file 3. For the
most common research areas, the proportion of stud-
ies which either: (1) did not report whether balance
assessment took place, (2) reported that balance as-
sessment took place, but did not report which diag-
nostic was used or (3) relied on eyeballing the data
for balance assessment, are given in Fig. 2, along with
95% confidence intervals. The equivalent proportions
and 95% confidence intervals for studies using: the
Hosmer-Lemeshow test, c-statistic, hypothesis tests,
standardised differences or “other” are given in Fig. 3.
The F-statistic associated with the multinomial regres-
sion model of diagnostic on research area had p-
value = 0.033, suggesting a possible difference in diag-
nostic use between research areas.
Across all research areas, studies in respiratory care
had the highest proportion of papers failing to report
whether or not diagnostics were used (30% [95% CI, 18–
44%]). In the remaining research areas, between 15 and
23% of studies failed to report this information.
There is little evidence for a difference in the use of
eye-balling or Hosmer-Lemeshow test between research
areas (as indicated by the overlapping confidence inter-
vals), however there were some differences in the use of
c-statistics, p-values (with hypothesis tests) and standar-
dised differences.
Cardiovascular studies had the highest reported use
of c-statistics (32% [95% CI, 25–40%]). For compari-
son, the research areas with the lowest reported use
of c-statistics were urology and nephrology (9% [95%
CI, 2–21%]) and respiratory care systems (6% [95%
CI, 1–16%]).
Fig. 3 The proportion (95% Confidence Interval) of studies using each diagnostic, by research area. ‘Other’ includes: absolute differences,
graphical approaches, post-matching c-statistic, regression, standardised bias, and variance ratios
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Most research areas had approximately 25–50% of pa-
pers reporting the use of p-values. The area with the
lowest proportion of reported use of p-values was infec-
tious diseases (24% [95% CI, 13–39%]), followed by
medicine general and internal (25% [95% CI, 16–36%]),
cardiovascular systems (34% [95% CI, 26–42%]) and per-
ipheral vascular disease (30% [95% CI, 13–39%]). Surgery
studies had the highest proportion of reported use of p-
values (56% [95% CI, 47–65%]).
On the other hand, surgery studies had the lowest pro-
portion of papers reporting use of standardised differ-
ences (19% [95% CI, 13–28%]). The remaining research
areas had at least 26% of papers reporting use of stan-
dardised differences and the highest proportion was in
studies on urology and nephrology (46% [95% CI, 31–
61%]).
Comparison of diagnostics between studies using
different propensity score methods
Of the 894 studies included, 693 (78%) used propensity
score matching, 57 (6%) used stratification, 106 (12%)
used covariate adjustment and 115 (13%) used weighted.
These percentages total to more than 100 because some
studies used multiple methods. Of those that reported
use of weighting, 108 used inverse-probability-of-treat-
ment weights, 3 used standardised-mortality-ratio
weighting, 1 used overlap weights and 3 did not report
which weights were used.
Figure 4 compares the proportions of studies using
each diagnostic by propensity score method used.
Studies using covariate adjustment for the propensity
score were most likely to not report whether diagnos-
tics were used. The proportion of covariate adjust-
ment studies failing to report this information was
69% [95% CI, 58–79%], whereas for stratified,
weighted and matched studies, the equivalent propor-
tions were 38% [95% CI, 21–56%], 26% [95% CI, 17–
37%] and 13% [95% CI, 10–16%] respectively.
While matched studies were the least likely to not re-
port whether diagnostics were used, they were the most
likely to report the use of p-values or standardised differ-
ences. Of the matched studies, 44% [95% CI, 40–48%]
Fig. 4 The proportion (95% Confidence Interval) of studies using each diagnostic, by propensity score method. Assessment not reported’ refers to
papers which did not specify whether propensity scores were assessed; ‘Diagnostic not reported’ refers to papers which reported that assessment
took place, but not how; ‘Other’ includes: absolute differences, graphical approaches, post-matching c-statistic, regression, standardised bias, and
variance ratios
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reported use of p-values, compared to 5% [95% CI, 1–
12%] for covariate adjustment studies, and 42% [95% CI,
38–46%] of matched studies reported use of standar-
dised differences, compared to 2% [95% CI, 0–8%] of co-
variate adjustment studies.
The proportion of reported use of eye-balling, the
Hosmer-Lemeshow test or the c-statistic to assess pro-
pensity scores was very similar between studies using
different methods. Although there were observed differ-
ences in the use of p-values, standardised difference and
proportion of studies not reporting assessment between
studies using different methods, the F-statistic associated
with the multinomial regression model of diagnostic on
propensity score method had p-value = 0.061, indicating
weak evidence for differences overall.
Discussion
A methodological review of 894 articles was conducted
to assess the use of propensity score diagnostics in med-
ical papers published in high-impact journals. Our re-
sults demonstrate that the use of propensity score
diagnostics is suboptimal, even in high-impact papers,
where best practice might be expected. Approximately
one fifth of authors did not report the use of any diag-
nostic, and of those who did, hypothesis tests were the
most common, despite the widespread discouragement
of their use.
The problem with hypothesis tests is that they are
dependent upon sample size and the hypotheses they
test are not relevant. The former disadvantage is particu-
larly problematic when matching; in the matched set an
apparent improvement in balance may be due to the loss
of statistical power after discarding observations. The
hypotheses are irrelevant since they aim to test whether
two population parameters are equal to each other,
using sample data assumed to be drawn from those pop-
ulations. However, when assessing propensity scores we
are only interested in whether or not balance has been
achieved in the sample used to estimate the treatment
effects.
Additionally, our results indicated that the Hosmer-
Lemeshow test and c-statistic were also among the most
commonly used diagnostics for propensity scores. These
diagnostics are traditionally used for logistic regression,
where the former measures goodness-of-fit. Although a
significant Hosmer-Lemeshow test can identify problems
with the propensity score model, it lacks power and
hence a non-significant result cannot be used as evi-
dence that a propensity score model is correct [31]. The
c-statistic measures model discrimination, which, in a
propensity score context, is the ability to predict treat-
ment assignment. However, propensity scores aim to
balance confounding variables, and this may not improve
with improved discrimination: including variables
associated with the exposure but not the outcome will
improve model discrimination, but may also increase
bias and variance in estimated treatment effects [32, 33].
For these reasons, we recommend against using logistic
regression diagnostics for propensity scores. An excep-
tion to this recommendation, is using the c-statistic as a
post-matching diagnostic [34]. If the propensity score
has adequately removed imbalances between treatment
groups, patient characteristics should have no associ-
ation with treatment assignment in the matched set. In
this case, c-statistics close to 0.5 indicate successful
balance.
Standardised differences were the most commonly
used diagnostic in our results, after hypothesis testing.
Standardised differences are preferred because they are
independent of sample size and are a property of the
sample [35]. It has been suggested that a standardised
difference of less than 0.1 can be considered as adequate
balance [36], however this is an arbitrary threshold. The
levels of acceptable imbalance will likely depend on the
strength of association between covariate and outcome:
stronger predictors of outcome will contribute more to-
wards confounding bias and balance should be priori-
tised on these variables [37]. Additionally, it is
recommended to check standardised differences in sec-
ond order moments and interaction terms, since failing
to do so may prevent sufficient balance being achieved
on non-linear or non-additive terms [13]. If sufficient
balance is not reached, authors may consider adding
higher order terms, three-way interactions, transforming
variables or re-categorising variables [38].
Whereas previous reviews [10, 11, 18–25] did not limit
their searches by journal impact factor, ours focused on
high-impact journals and despite the differences in in-
clusion criteria there were still similarities in our results.
Previous reviews [10, 11, 18–25] found that between 11
and 59% (20.9% in the current study) of authors did not
report the use of any diagnostic; − unfortunately, there
is no evidence to suggest that this percentage is decreas-
ing over time. Furthermore, most previous reviews [10,
11, 18–20, 22–25] also found that hypothesis tests were
the most common diagnostic (the only review [21] that
did not report this finding did not go into detail about
which diagnostics were used). We add to the current lit-
erature by demonstrating that even in high-impact jour-
nals, where we might expect best practice to be more
common, many authors are still not reporting diagnostic
use, or reporting use of suboptimal diagnostics. How-
ever, comparing our results to previous reviews does
suggest an increase in the use of standardised differences
over time. Including this one, three reviews reported the
proportion of papers using standardised differences and
considered papers across all areas of medicine. The pro-
portions and publication years (breaking down our
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results by year) in increasing order were: 4% (1996–
2003), 15% (2011–2012), 34% (2014), 35% (2015) and
42% (2016). The increase in use of standardised differ-
ences could be a result of the recent published recom-
mendations for their use [10–17].
Our results indicated that there were some differences
in diagnostic use between different research areas. It is
likely that authors will read papers within their own area
and follow the apparent norm when implementing these
methods in their own work. Therefore, diagnostic use
could improve if tutorial papers with best practice exam-
ples were published in the leading journals of those re-
search areas where suboptimal practice is most
common. When comparing diagnostic use between
studies using different propensity score methods, we ob-
served large differences in the reported use of diagnos-
tics in matched studies compared to the other
propensity score methods: matched studies were less
likely to omit reporting diagnostic use and more likely
to use standardised differences. By matching subjects’ re-
sults in distinct treatment groups, it is easy to compare
means between groups, and so it is arguably easier to
comprehend how to implement standardised differences
when matching compared to the alternative methods.
This could be the reason for the disparity in reported
diagnostic use between matching and other methods.
Fortunately there is existing guidance on how to use
propensity score diagnostics when weighing [39] or
using covariate adjustment [40], and well as when
matching [13].
A limitation of the current study is that information
regarding diagnostic use and propensity score method
was only obtained manually by one author. However, we
used a full-text search program to identify papers using
three of the more commonly used diagnostics and thus
could check for discrepancies. This revealed only a few
errors; therefore, we assume that the manual search was
similarly reliable for the other diagnostics. Secondly, the
research areas are not necessarily categorised in the
most informative way. Creating distinct and meaningful
categories was challenging and there are a number of
ways in which research areas could have been arbitrarily
defined. We felt it was best to make use of a system
already in place by using categories defined on the JCR
website. Thirdly, our search may not have revealed all
relevant literature. A recent study [41] found that many
articles that use a particular methodology do not report
its use in the title or abstract. Consequently, our review
could have missed relevant articles which use propensity
score methods. Moreover, by defining our search terms
as “propensity score” or “propensity matched”, it is pos-
sible that studies using inverse probability of treatment
weighting could be underrepresented. However, the pro-
portion of studies in our results that used this weighting
method (12%) is similar to that observed in other re-
views [11, 22–25] on the use of propensity scores (0–
14%).
Finally, regarding diagnostic use, we only collected in-
formation on which diagnostics were used and not on
how they were implemented. For example, when stan-
dardised differences are used, they may be used to check
balance in different samples (e.g. a matched set or a
weighted sample), different thresholds for acceptable
balance may be used and residual imbalance s may be
handled in a variety of ways. Future research could in-
vestigate how propensity score diagnostics are imple-
mented in the medical literature: this could help inform
best practice.
Conclusions
In conclusion, the use of diagnostics in the propensity
score literature remains suboptimal. Many authors are
still failing to report whether diagnostics were used to
assess the propensity score. However, over time we have
seen some improvement. Standardised differences are
currently the most widely recommended diagnostic and
we have seen an increase in their use compared to previ-
ous reviews. Additionally, we identified the research
areas in which suboptimal practice was most common.
The propensity score literature may benefit from focused
efforts to improve practice in these areas. .
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